Jesse Shefferman - 10 Jan 2023 Form 4 Insider Report for Protara Therapeutics, Inc. (TARA)

Role
CEO and President, Director
Signature
/s/ Mary Grendell, Attorney-In-Fact
Issuer symbol
TARA
Transactions as of
10 Jan 2023
Net transactions value
-$17,565
Form type
4
Filing time
11 Jan 2023, 15:03:47 UTC
Previous filing
04 Jan 2023
Next filing
20 Jan 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TARA Common Stock Tax liability $17,565 -5,855 -0.67% $3.00 866,982 10 Jan 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy income tax obligations associated with the vesting of a Restricted Stock Unit Award granted to the Reporting Person on January 10, 2020.